OKYO
Price
$1.14
Change
+$0.01 (+0.88%)
Updated
Nov 8, 03:18 PM (EDT)
21 days until earnings call
URGN
Price
$12.16
Change
+$0.06 (+0.50%)
Updated
Nov 8, 03:40 PM (EDT)
125 days until earnings call
Ad is loading...

OKYO vs URGN

Header iconOKYO vs URGN Comparison
Open Charts OKYO vs URGNBanner chart's image
OKYO Pharma
Price$1.14
Change+$0.01 (+0.88%)
Volume$1.9K
CapitalizationN/A
UroGen Pharma
Price$12.16
Change+$0.06 (+0.50%)
Volume$500
CapitalizationN/A
View a ticker or compare two or three
OKYO vs URGN Comparison Chart
Loading...
OKYO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
OKYO vs. URGN commentary
Nov 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OKYO is a Hold and URGN is a StrongSell.

COMPARISON
Comparison
Nov 08, 2024
Stock price -- (OKYO: $1.13 vs. URGN: $12.10)
Brand notoriety: OKYO and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OKYO: 48% vs. URGN: 49%
Market capitalization -- OKYO: $38.24M vs. URGN: $509.58M
OKYO [@Biotechnology] is valued at $38.24M. URGN’s [@Biotechnology] market capitalization is $509.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OKYO’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • OKYO’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both OKYO and URGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OKYO’s TA Score shows that 5 TA indicator(s) are bullish while URGN’s TA Score has 4 bullish TA indicator(s).

  • OKYO’s TA Score: 5 bullish, 4 bearish.
  • URGN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, URGN is a better buy in the short-term than OKYO.

Price Growth

OKYO (@Biotechnology) experienced а -4.24% price change this week, while URGN (@Biotechnology) price change was -1.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was +14.54%, and the average quarterly price growth was +11.61%.

Reported Earning Dates

OKYO is expected to report earnings on Feb 26, 2025.

URGN is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
URGN($510M) has a higher market cap than OKYO($38.2M). URGN YTD gains are higher at: -19.333 vs. OKYO (-36.158).
OKYOURGNOKYO / URGN
Capitalization38.2M510M7%
EBITDAN/A-94.89M-
Gain YTD-36.158-19.333187%
P/E RatioN/AN/A-
RevenueN/A85M-
Total CashN/A241M-
Total DebtN/A98.2M-
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OKYOURGN
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
OKYO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KMB132.250.61
+0.46%
Kimberly-Clark Corp
APOG83.70-0.42
-0.50%
Apogee Enterprises
FTEK1.02-0.01
-0.97%
Fuel Tech
HBCP49.33-0.67
-1.34%
Home Bancorp
ASH80.70-6.68
-7.64%
Ashland

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and MEIP have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and MEIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
+0.89%
MEIP - OKYO
24%
Poorly correlated
-0.33%
CLNN - OKYO
24%
Poorly correlated
+2.97%
AKBA - OKYO
23%
Poorly correlated
-6.75%
URGN - OKYO
22%
Poorly correlated
-1.14%
INZY - OKYO
22%
Poorly correlated
-3.07%
More

URGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with CYYNF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
-1.14%
CYYNF - URGN
38%
Loosely correlated
N/A
SPRB - URGN
32%
Poorly correlated
+0.68%
ORMP - URGN
28%
Poorly correlated
+1.71%
RZLT - URGN
28%
Poorly correlated
-1.55%
GOSS - URGN
27%
Poorly correlated
-0.02%
More